Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Kura Oncology, Inc.
Dana-Farber Cancer Institute
AvenCell Therapeutics, Inc.
Fate Therapeutics
Center for International Blood and Marrow Transplant Research
Allogene Therapeutics
Ossium Health, Inc.
Center for International Blood and Marrow Transplant Research
Case Comprehensive Cancer Center
St. Jude Children's Research Hospital
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
Therapeutic Advances in Childhood Leukemia Consortium
University of Pennsylvania
National Institutes of Health Clinical Center (CC)
Actinium Pharmaceuticals
Anhui Provincial Hospital
Masonic Cancer Center, University of Minnesota
University of Pennsylvania
Thomas Jefferson University
Affiliated Hospital of Nantong University
Vastra Gotaland Region
Celgene
M.D. Anderson Cancer Center
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
National Institutes of Health Clinical Center (CC)
Fate Therapeutics
M.D. Anderson Cancer Center
Weill Medical College of Cornell University
Memorial Sloan Kettering Cancer Center
Medical College of Wisconsin
St. Jude Children's Research Hospital
The Affiliated People's Hospital of Ningbo University
Loyola University
Memorial Sloan Kettering Cancer Center
University Hospital Schleswig-Holstein
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Therapeutic Advances in Childhood Leukemia Consortium
Icahn School of Medicine at Mount Sinai
M.D. Anderson Cancer Center
University of Chicago
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota